Kennedy Capital Management, Inc. Day One Biopharmaceuticals, Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.27 Billion
- Q3 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 189,297 shares of DAWN stock, worth $2.71 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
189,297
Previous 173,738
8.96%
Holding current value
$2.71 Million
Previous $2.39 Million
10.11%
% of portfolio
0.06%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
175Shares Held
83.4MCall Options Held
114KPut Options Held
167K-
Ra Capital Management, L.P. Boston, MA7.87MShares$113 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$92.1 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$84.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$69.8 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$64.9 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.05B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...